B7/CD28 interaction inhibitor 1
This small molecule compound is a potent and selective inhibitor of CTLA-4, effectively blocking the B7/CD28 interaction. It is a valuable research tool for studying T-cell activation and immune checkpoint pathways in both in vitro cellular assays and in vivo models of immunology and oncology.
Product Specifications
CAS Number
635324-72-0
Product Name Alternative
CD28, CTLA-4, CTLA-4 inhibitor, antibodies, B7.1, B7/CD28 interaction inhibitor 1, B-7/CD28 interaction inhibitor 1, Inhibitor, inhibit, immunosuppression, responses, T-cell
Field of Research
Immunology & Inflammation, Immunology & Inflammation; Pharmacology & Drug Discovery
Purity
98.89% (May vary between batches)
Solubility
DMSO:85 mg/mL (198.9 mM)
Smiles
Cn1ncc2c1nc (-c1cccc (c1) C (F) (F) F) c1c2[nH]n (-c2ccc (F) cc2) c1=O
Molecular Formula
C21H13F4N5O
Molecular Weight
427.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog